安体舒通

Ān tǐ shū tōnɡ
  • Spironolactone;Aldactone
安体舒通安体舒通
  1. 安体舒通对感觉神经损伤性盐敏感性高血压大鼠血管重构及RAAS的影响

    The effects of aldactone on the vascular remodeling and RAAS in the salt-sensitive hypertensive rats induced by sensory denervation

  2. 目的观察安体舒通对感觉神经损伤性盐敏感高血压大鼠模型血管重构及肾素-血管紧张素-醛固酮系统(RAAS)的影响。

    Objective To determine the effects of aldactone on the vascular remodeling and Renin-Angiotensin-Aldosterone System ( RAAS ) in the salt-sensitive hypertensive rat model induced by sensory denervation .

  3. 所有患者均行血醛固酮测定、安体舒通试验及B超、CT检查。

    All patients were done serum aldosterone assay , spironolactone test and were examed B ultrasonography and CT .

  4. 美托洛尔和安体舒通对CHF患者QT间期离散度的影响

    Effects of Metoprolol and Spironolactone on QT Dispersion in Patients with CHF

  5. 安体舒通减轻博莱霉素A5引起的大鼠肺纤维化

    Spironolactone ameliorates rat pulmonary fibrosis induced by bleomycin A 5

  6. 安体舒通每天剂量不应超过20mg。

    Daily dosage of spironolactone should not be over 20 mg .

  7. ACEI联合小剂量安体舒通对左室重构和胶原更新的影响

    The effects of ACEI and a low dose of spironolactone on the left ventricular remodeling and the turnover of myocardial collagen

  8. Carson说,这些受试者有良好的基础治疗,使用安体舒通和β受体阻滞剂在研究期间明显增加。

    The subjects were well-treated at baseline , said Carson , and spironolactone and beta-blocker use increased markedly during the study period .

  9. 目的分析血管紧张素转换酶抑制剂(ACEI)与安体舒通在联合治疗心力衰竭(心衰)或高血压等疾病中发生严重高钾血症的危险因素和发生率。

    Objective To analyze risk factors and morbidity of serious hyperkalemia during combined treatment with angiotensin-converting enzyme inhibitors ( ACEI ) and spironolactone .

  10. 目的评价醛固酮受体拮抗剂安体舒通和血管紧张素Ⅱ受体拮抗剂替米沙坦对心肌梗死(AMI)不伴有心功能异常大鼠的作用和相关激素表达的影响。

    Objectives To evaluate the effect of mineralocorticoid receptor antagonist ( MRA ) spironolactone and angiotensin ⅱ receptor blockade ( ARB ) telmisartan on post-infarct left ventricular without ventricular dysfunction and the role of the cardiac steroidogenic system .

  11. 结论安体舒通能降低ISH患者的SBP,显著改善异常的血压节律,有益于老年ISH患者减轻靶器官损害,降低心血管疾病的风险。

    Conclusion Spironolactone can decrease SBP in ISH patients and improve blood pressure rhythm , and can relieve the damage of target organs and reduce the risk of cardiovascular diseases .

  12. 结论PRA-AⅡ-ALD测定、安体舒通试验等是PA的主要定性方法,PA定位主要依靠肾上腺B超、MRI、CT及SCT检查,治疗的主要方法是手术。

    Conclusion PRA-A ⅱ - ALD test and spironolactone test were the main methods of PA qualitative diagnosis . B ultrasonography , MRI and CT / SCT were useful to the location of PA , the main treatment methods of PA were surgical .

  13. 安体舒通在治疗67例慢性充血性心力衰竭中的作用

    Effects of antisterone on the treatment of congestive chronic heart failure

  14. 悦宁定与安体舒通长期联合应用具有良好的耐受性。

    The combined use of triamterene and enalapril was well tolerant .

  15. 安体舒通对老年单纯收缩期高血压的作用

    Effect of spironolactone on simple systolic hypertension in the elderly

  16. 安体舒通抗肝纤维化作用实验性研究

    Experimental investigation of the effect of aldosterone on liver fibrosis

  17. 安体舒通对大鼠慢性环孢素A肾毒性的保护作用

    Protective effects of Spironolactone on chronic cyclosporine A nephrotoxicity in rat models

  18. 洛沙坦和安体舒通对肾血管性高血压大鼠心血管肥厚的作用

    Effect of Losartan and Spironolactone on Cardiovascular Hypertrophy in Renovascular Hypertensive Rats

  19. 安体舒通和缬沙坦对肾小管上皮细胞凋亡的影响

    The effects of spironolactone and valsartan on apoptosis of renal tubular epithelial cell

  20. 咪达普利和安体舒通对慢性心力衰竭大鼠心肌纤维化的干预研究

    Research on Imidapril and Spironolactone Regressing Ventricular Fibrosis in Rat with Chronic Heart Failure

  21. 培哚普利和安体舒通对实验性高血压大鼠心肌基质胶原重构的影响

    Effects of Perindopril and Spironolactone on Myocardial Collagen Matrix Remodeling in Experimental Hypertensive Rats

  22. 缬沙坦与安体舒通联合治疗对原发性高血压心肌细胞外基质重塑的影响

    Effect of Valsartan and Spironolactone Combination Treatment on Myocardial Extracellular Matrix Remodeling in Essential Hypertension

  23. 目的研究和评估安体舒通对实验性大鼠肝纤维化的防治作用,探讨其抗肝纤维化作用的可能机制。

    Aim To study the effect and mechanism of aldosterone on experimental rat liver fibrosis .

  24. 安体舒通对自发性高血压大鼠肺组织胶原形成的抑制作用

    The inhibition of spironolactone on the collagen biosynthesis of lung tissues in spontaneously hypertensive rats

  25. 安体舒通治疗寻常痤疮疗效观察

    Spironolactone in treatment of acne vulgaris

  26. 缬沙坦和安体舒通对急性心肌梗死后基质金属蛋白酶和胶原代谢以及心功能的影响

    Effects of Valsartan and Spironolactone on Matrix Metalloproteinases , Collagen Metabolism and Heart Function in Post-myocardial Infarction

  27. 苯那普利和安体舒通联合应用治疗慢性心衰室性心律失常的临床研究

    The Clinical Study of Combined Use of Benazepril and Antisterone in Treatment of Ventricular Arrhythmias of Chronic Heart-Failure

  28. 我也想了解这个问题,我正在考虑使用安体舒通乳液。

    I would like to know the answer to this as well as I am considering topical spiro .

  29. 醛固酮受体拮抗剂,尤其是小剂量安体舒通干预糖尿病肾病的临床和基础研究。

    Aldosterone receptor antagonist , especially clinical and basic study of small dose of spironolactone in intervening diabetic nephropathy .

  30. 结论安体舒通能够抑制充血性心力衰竭患者心肌纤维化和改善心室重塑。

    Objective : To evaluate the effects of spironolactone on the myocardial fibrosis and left ventricular remodeling in patients with congestive heart failure .